Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1 or anti-PD-L1 antibody

Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1 or anti-PD-L1 antibody

US Patent 11723975 · Granted Aug 15, 2023

Estimated economic value: $788,377,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19/anti-CD38 common light chain bispecific antibodies2025
Antibodies binding to ILT42025
CD19/CD38 multispecific antibodies2024
Treatment of LAG-3 positive tumors2024
Treatment of LAG-3 positive tumors2023
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) 2023
Anti-GITR antibodies for cancer diagnostics2022
Antibodies binding to ILT42022
Antibodies against CD73 and uses thereof2022
Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and u2022
Composite binding molecules targeting immunosuppressive B cells2022
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors2022